Cardinal Health holder plans sale of 4,000 shares

Cardinal Health received a notice of proposed sale under Rule 144 for its common stock.

Rhea-AI Filing Summary

Cardinal Health received a notice of proposed sale under Rule 144 for its common stock. A holder who acquired shares as board compensation on 11/06/2019 and 11/04/2020 plans to sell 4,000 common shares through Merrill Lynch on the NYSE around 02/06/2026, with an aggregate market value of 918,760. Cardinal Health had 235,316,016 common shares outstanding at the time referenced in the notice.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Cardinal Health (CAH) Form 144 filing disclose?

The filing discloses a planned sale of 4,000 Cardinal Health common shares. The shares were previously granted as board compensation and will be sold on the NYSE through Merrill Lynch, with an aggregate market value of 918,760 stated in the notice.

How many Cardinal Health (CAH) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 4,000 Cardinal Health common shares. These came from board compensation awards in 2019 and 2020 and are planned for sale on the NYSE using Merrill Lynch as the broker.

When is the planned sale date for the Cardinal Health (CAH) shares in this Form 144?

The approximate sale date indicated is 02/06/2026. This target date applies to the proposed sale of 4,000 Cardinal Health common shares under Rule 144 on the NYSE through Merrill Lynch as the designated broker.

What is the aggregate market value of Cardinal Health (CAH) shares in this planned sale?

The filing lists an aggregate market value of 918,760 for the 4,000 common shares. This figure reflects the holder’s estimate at the time of the notice for the planned NYSE sale handled by Merrill Lynch.

How were the Cardinal Health (CAH) shares being sold under Form 144 acquired?

The 4,000 common shares were acquired as board compensation from Cardinal Health. The notice identifies two grants dated 11/06/2019 and 11/04/2020, both recorded as non-cash compensation with payment nature described as N/A.

How many Cardinal Health (CAH) shares were outstanding according to the Form 144?

The notice states that 235,316,016 Cardinal Health common shares were outstanding. This number serves as a baseline context for the proposed 4,000-share sale under Rule 144 on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001517890
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cardinal Health
SEC File Number	001-11373
Address of Issuer	7000 Cardinal Place Dublin OHIO 43017
Phone	6147573033
Name of Person for Whose Account the Securities are To Be Sold	Patricia Hemingway Hall
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Place 5th Floor Columbus OH 43240	4000	918760	235316016	02/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/06/2019	Board compensation	Cardinal Health			576	11/06/2019	N/A
Common	11/04/2020	Board Compensation	Cardinal Health			3424	11/04/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Patricia Hemingway Hall
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)